Supplements

CGM-guided dietary titration improves Time in Range in GSD patients

In interventional settings, CGM-guided dietary titration improved Time in Range from 72% to 86% in gene therapy trials, and reduced serum triglycerides and liver size. CGM consistently identified asymptomatic hypoglycemia, with adult cohorts spending up to 12% of time below range despite normal spot checks.

Last updated: Jul 7, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score38/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Continuous Glucose Monitoring in Glycogen Storage Diseases: A Systematic Review of Clinical Utility, Accuracy and Patient Outcomes.

observational

Mohsenipour R, Abbasi F, Ghaderian MS, Dehkordi AK, Abdolahpour S, Akbari K · Endocrinology, diabetes & metabolism (2026)

Participants: N/A
Duration: N/A
Intervention: CGM-guided dietary titration
Outcome: Time in Range (TIR), serum triglycerides, liver size
Effect Size: N/A
Population: Patients with hepatic Glycogen Storage Diseases (GSD), predominantly GSD Ia, Ib and III

Result:

PubMed: 42394382DOI: 10.1002/edm2.70274

Mechanism Graph

CGM provides continuous glucose data
↓
Data enables precise dietary adjustments
↓
Dietary titration stabilizes glucose levels
↓
Result: improved Time in Range and reduced metabolic markers

Limitations

  • ⚠Sensor performance showed a positive bias in the hypoglycemic range, potentially masking severe neuroglycopenia
  • ⚠CGM introduced 'alarm fatigue' from false-positive alerts

Frequently Asked Questions

What is the main benefit of CGM in GSD?▼

CGM offers superior sensitivity for detecting occult (asymptomatic) hypoglycemia and guiding dietary therapy, potentially shifting management from reactive treatment to proactive stabilization.

What are the downsides of CGM in GSD patients?▼

Sensor inaccuracy at lower glucose levels (positive bias) may mask severe neuroglycopenia, and constant surveillance can lead to alarm fatigue from false-positive alerts.

How much time do GSD adults spend below glucose range despite normal spot checks?▼

Adult cohorts spent up to 12% of time below range (< 70 mg/dL) despite normal spot checks.

What improvements were seen with CGM-guided dietary titration in gene therapy trials?▼

Time in Range improved from 72% to 86%, and reductions in serum triglycerides and liver size were observed.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Mohsenipour R, Abbasi F, Ghaderian MS, Dehkordi AK, Abdolahpour S, Akbari K. "Continuous Glucose Monitoring in Glycogen Storage Diseases: A Systematic Review of Clinical Utility, Accuracy and Patient Outcomes.." Endocrinology, diabetes &amp; metabolism, 2026. PMID: 42394382 DOI: 10.1002/edm2.70274
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.